186 related articles for article (PubMed ID: 33216956)
1. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
Khanlari M; Tang G; Hao S; Gong Y; Li S; Miranda RN; Lin P; Iyer S; Yin CC; Xie W; Vega F; Medeiros LJ; Xu J
Br J Haematol; 2021 Jan; 192(1):e17-e21. PubMed ID: 33216956
[No Abstract] [Full Text] [Related]
2. "Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements.
Luo DX; Li W; Ye MT; Yang Y; Tang G; You MJ
Am J Hematol; 2020 Dec; 95(12):1625-1627. PubMed ID: 32833271
[No Abstract] [Full Text] [Related]
3. Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma.
Chen Z; Chai F; Xi Y; Zhang H; Xu Y; Zhang Z; Li S; Tian X
J Cancer Res Clin Oncol; 2022 Jan; 148(1):267-278. PubMed ID: 34131801
[TBL] [Abstract][Full Text] [Related]
4. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma.
Liang X; Branchford B; Greffe B; McGavran L; Carstens B; Meltesen L; Albano EA; Quinones R; Cook B; Graham DK
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e209-13. PubMed ID: 23619105
[TBL] [Abstract][Full Text] [Related]
5. RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma.
Ahmed N; Ketterling RP; Nowakowski GS; Dasari S; Feldman AL
Histopathology; 2022 Aug; 81(2):275-278. PubMed ID: 35586895
[No Abstract] [Full Text] [Related]
6. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma.
Lyapichev KA; Tang G; Li S; You MJ; Cheng TJ; Miranda RN; Iyer S; Yin CC; Konoplev S; Bueso-Ramos C; Vega F; Medeiros LJ; Xu J
Hum Pathol; 2021 Feb; 108():22-31. PubMed ID: 33221344
[TBL] [Abstract][Full Text] [Related]
7. Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
Aarakaki H; Karube K
Blood; 2022 Jan; 139(3):465. PubMed ID: 35050329
[No Abstract] [Full Text] [Related]
8. Leukemic presentation of a highly aggressive ALK-negative anaplastic large cell lymphoma.
Xu D; Naresh KN
Blood; 2021 Sep; 138(13):1198. PubMed ID: 34591095
[No Abstract] [Full Text] [Related]
9. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
Jaye DL; Feldman AL
Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
[No Abstract] [Full Text] [Related]
10. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC.
Moritake H; Shimonodan H; Marutsuka K; Kamimura S; Kojima H; Nunoi H
Am J Hematol; 2011 Jan; 86(1):75-8. PubMed ID: 21080342
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
12. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma.
Shen J; Medeiros LJ; Li S; Wang SA; Lin P; Khanlari M; Iyer SP; Yin CC; Tang G; Jorgensen JL; Hu S; Miranda RN; Xu J
Hum Pathol; 2020 Apr; 98():1-9. PubMed ID: 32032618
[TBL] [Abstract][Full Text] [Related]
13. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Boddicker RL; Feldman AL
Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
[No Abstract] [Full Text] [Related]
14.
Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
[No Abstract] [Full Text] [Related]
16. Genetics of anaplastic large cell lymphoma.
Zeng Y; Feldman AL
Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
[TBL] [Abstract][Full Text] [Related]
17. JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
Le K; Wellik LE; Maurer MJ; McPhail ED; Witzig TE; Gupta M
Blood Cancer J; 2021 Mar; 11(3):56. PubMed ID: 33712566
[No Abstract] [Full Text] [Related]
18. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system relapse of systemic ALK-rearranged anaplastic large cell lymphoma treated with alectinib.
Tomlinson SB; Sandwell S; Chuang ST; Johnson MD; Vates GE; Reagan PM
Leuk Res; 2019 Aug; 83():106164. PubMed ID: 31226541
[No Abstract] [Full Text] [Related]
20. Primary central nervous system ALK-positive anaplastic large cell lymphoma with CD56 abnormally expression in a Chinese child: Challenge in diagnostic practice.
Liu Q; Chen X; Li G; Ye Y; Liu W; Zhao S; Zhang W
Int J Immunopathol Pharmacol; 2020; 34():2058738420941756. PubMed ID: 32664812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
